Early-onset VEXAS syndrome mimicking orbital cellulitis and successfully treated with allogeneic hematopoietic stem cell transplantation
Authors:
- 6 October 2026
- journal article
- case report
- Published by Springer Nature in Journal of Hematopathology
- Vol. 19 (1) , 62
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and managementAmerican Journal of Hematology, 2023
- Challenging the paradigm: a case of early-onset VEXAS syndromeRheumatology, 2023
- Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesisBlood, 2022
- Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experienceBlood Advances, 2022
- Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*British Journal of Dermatology, 2021
- Clinical Heterogeneity of the VEXAS SyndromeMayo Clinic Proceedings, 2021
- Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1Blood Advances, 2021
- Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXASArthritis & Rheumatology, 2021
- Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory DiseaseNew England Journal of Medicine, 2020
- Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathwaysNature Reviews Molecular Cell Biology, 2009